MyDocHub Blog - Online Health Community

Researchers report in the Lancet that a new vaccine against rotavirus, a gastroenteritis bug responsible for sometimes lethal diarrhea in infants and young children, shows promise in a new trial and might help save children’s lives.

A team from the University of Tampere, Finland, tested the RIX4414 vaccine in almost 4,000 infants six to 14 weeks of age, living in six European countries. After receiving two doses, children showed more than 90 percent protection against severe gastroenteritis over two seasons. The shot was also 96 percent effective in preventing illness requiring hospitalization.

Share This